Medtronic Research and Development Expenses 2010-2024 | MDT
- Medtronic research and development expenses for the quarter ending January 31, 2024 were $0.695B, a 1.02% increase year-over-year.
- Medtronic research and development expenses for the twelve months ending January 31, 2024 were $2.701B, a 0.26% decline year-over-year.
- Medtronic annual research and development expenses for 2023 were $2.696B, a 1.82% decline from 2022.
- Medtronic annual research and development expenses for 2022 were $2.746B, a 10.15% increase from 2021.
- Medtronic annual research and development expenses for 2021 were $2.493B, a 6.95% increase from 2020.
Medtronic Annual Research and Development Expenses (Millions of US $) |
|
---|---|
2023 | $2,696 |
2022 | $2,746 |
2021 | $2,493 |
2020 | $2,331 |
2019 | $2,330 |
2018 | $2,256 |
2017 | $2,193 |
2016 | $2,224 |
2015 | $1,640 |
2014 | $1,477 |
2013 | $1,557 |
2012 | $1,490 |
2011 | $1,472 |
2010 | $1,424 |
2009 | $1,355 |
Medtronic Quarterly Research and Development Expenses (Millions of US $) |
|
---|---|
2024-01-31 | $695 |
2023-10-31 | $698 |
2023-07-31 | $668 |
2023-04-30 | $640 |
2023-01-31 | $688 |
2022-10-31 | $676 |
2022-07-31 | $692 |
2022-04-30 | $652 |
2022-01-31 | $668 |
2021-10-31 | $676 |
2021-07-31 | $750 |
2021-04-30 | $632 |
2021-01-31 | $601 |
2020-10-31 | $639 |
2020-07-31 | $621 |
2020-04-30 | $568 |
2020-01-31 | $573 |
2019-10-31 | $603 |
2019-07-31 | $587 |
2019-04-30 | $594 |
2019-01-31 | $561 |
2018-10-31 | $590 |
2018-07-31 | $585 |
2018-04-30 | $592 |
2018-01-31 | $559 |
2017-10-31 | $556 |
2017-07-31 | $549 |
2017-04-30 | $553 |
2017-01-31 | $530 |
2016-10-31 | $554 |
2016-07-31 | $556 |
2016-04-30 | $575 |
2016-01-31 | $546 |
2015-10-31 | $545 |
2015-07-31 | $558 |
2015-04-30 | $528 |
2015-01-31 | $373 |
2014-10-31 | $374 |
2014-07-31 | $365 |
2014-04-30 | $385 |
2014-01-31 | $360 |
2013-10-31 | $372 |
2013-07-31 | $360 |
2013-04-30 | $409 |
2013-01-31 | $376 |
2012-10-31 | $387 |
2012-07-31 | $385 |
2012-04-30 | $393 |
2012-01-31 | $364 |
2011-10-31 | $371 |
2011-07-31 | $362 |
2011-04-30 | $367 |
2011-01-31 | $362 |
2010-10-31 | $373 |
2010-07-31 | $370 |
2010-04-30 | $341 |
2010-01-31 | $344 |
2009-10-31 | $369 |
2009-07-31 | $370 |
2009-04-30 | $368 |
2009-01-31 | $337 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $107.939B | $31.227B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.688B | 24.51 |
Stryker (SYK) | United States | $127.423B | 31.59 |
Boston Scientific (BSX) | United States | $101.215B | 33.65 |
EssilorLuxottica (ESLOY) | France | $99.656B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.872B | 0.00 |
Haleon (HLN) | United Kingdom | $38.401B | 30.04 |
ResMed (RMD) | United States | $27.097B | 27.09 |
Terumo (TRUMY) | Japan | $25.416B | 35.90 |
Zimmer Biomet Holdings (ZBH) | United States | $24.968B | 16.07 |
Baxter (BAX) | United States | $20.831B | 15.19 |
Koninklijke Philips (PHG) | Netherlands | $19.511B | 15.56 |
Insulet (PODD) | United States | $11.713B | 61.50 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.842B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.136B | 24.24 |
BellRing Brands (BRBR) | United States | $7.357B | 39.56 |
Lantheus Holdings (LNTH) | United States | $4.415B | 11.40 |
Haemonetics (HAE) | United States | $4.320B | 22.10 |
Perrigo (PRGO) | Ireland | $4.132B | 11.82 |
GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
Prestige Consumer Healthcare (PBH) | United States | $3.536B | 16.72 |
Envista Holdings (NVST) | United States | $3.475B | 13.22 |
QuidelOrtho (QDEL) | United States | $2.702B | 9.81 |
Neogen (NEOG) | United States | $2.666B | 25.65 |
Green Thumb Industries (GTBIF) | United States | $2.566B | 81.33 |
ICU Medical (ICUI) | United States | $2.382B | 17.77 |
TG Therapeutics (TGTX) | United States | $2.202B | 712.50 |
Owens & Minor (OMI) | United States | $1.959B | 18.80 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.941B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.662B | 0.00 |
National Vision Holdings (EYE) | United States | $1.475B | 45.95 |
InMode (INMD) | Israel | $1.459B | 7.55 |
LeMaitre Vascular (LMAT) | United States | $1.442B | 47.58 |
Warby Parker (WRBY) | United States | $1.318B | 0.00 |
AdaptHealth (AHCO) | United States | $1.304B | 9.81 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $1.015B | 0.00 |
Canopy Growth (CGC) | Canada | $0.905B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.701B | 15.15 |
Cresco Labs (CRLBF) | United States | $0.695B | 0.00 |
Evolus (EOLS) | United States | $0.678B | 0.00 |
Quanterix (QTRX) | United States | $0.616B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.551B | 11.94 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Valneva SE (VALN) | France | $0.539B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.492B | 0.00 |
PetIQ (PETQ) | United States | $0.489B | 18.24 |
ZimVie (ZIMV) | United States | $0.437B | 26.75 |
OraSure Technologies (OSUR) | United States | $0.423B | 7.00 |
Biote (BTMD) | United States | $0.415B | 3.95 |
Aurora Cannabis (ACB) | Canada | $0.405B | 0.00 |
Surmodics (SRDX) | United States | $0.383B | 41.42 |
Zynex (ZYXI) | United States | $0.362B | 41.70 |
Viemed Healthcare (VMD) | United States | $0.312B | 31.00 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.273B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.242B | 14.78 |
Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.191B | 0.00 |
Veru (VERU) | United States | $0.187B | 0.00 |
Omeros (OMER) | United States | $0.179B | 0.00 |
High Tide (HITI) | Canada | $0.170B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.164B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.152B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.132B | 66.41 |
FitLife Brands (FTLF) | United States | $0.129B | 20.70 |
InterCure (INCR) | Israel | $0.118B | 20.00 |
Fonar (FONR) | United States | $0.101B | 8.70 |
Cellectar Biosciences (CLRB) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.086B | 0.00 |
Chimerix (CMRX) | United States | $0.083B | 0.00 |
Brainsway (BWAY) | Israel | $0.082B | 0.00 |
Safety Shot (SHOT) | United States | $0.080B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.04 |
Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.54 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
GlucoTrack (GCTK) | United States | $0.020B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 75.27 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |